NCT01562548View on ClinicalTrials.gov

Exploratory Efficacy Study of Guaifenesin in Upper Back Pain

NACompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Upper Back Pain
Interventions
DRUG

Guaifenesin

high and low dose of Guaifenesin each given twice daily over a 4-day treatment period

DRUG

Placebo

no active ingredient

Trial Locations (5)

45249

Radiant Research - Cincinnati, Cincinnati

78229

Radiant Research, Inc. - TX, San Antonio

84109

J. Lewis Research, Salt Lake City

92120

San Diego Sports Medicine and Family Health Center, San Diego

95628

Med Investigations, Fair Oaks

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01562548 - Exploratory Efficacy Study of Guaifenesin in Upper Back Pain | Biotech Hunter | Biotech Hunter